{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:56:18Z","timestamp":1791190578870,"version":"4.1.0"},"reference-count":142,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Esophageal cancer (EC) is a highly prevalent and aggressive gastrointestinal malignancy. Late diagnosis and heterogeneous responses to chemoradiotherapy and immune checkpoint inhibitor (ICI) therapies severely challenge clinical management. Accumulating evidence suggests that gut microbiota dysbiosis influences esophageal mucosal malignant transformation, tumor progression, and therapeutic outcomes through the gut-esophageal axis. However, most existing research remains correlational. To bridge this gap, this review critically synthesizes the dysbiosis signatures of EC and establishes a five-tier evidence grading framework to rigorously distinguish causal mechanisms from preclinical inferences. This microbial regulation is predominantly driven by metabolite-mediated signaling, remodeling of the tumor immune microenvironment (TME), intestinal barrier disruption, and oncogenic pathway activation. We functionally classify EC-associated dysbiosis into pro-tumorigenic, anti-tumorigenic, and context-dependent taxa, emphasizing a multidimensional ecosystem perspective. Furthermore, we evaluate the utility of gut microbial signatures as predictive biomarkers for neoadjuvant therapy and prognosis. Microbiota-targeted intervention strategies, including fecal microbiota transplantation (FMT), microecological preparations, and Traditional Chinese Medicine (TCM), have entered clinical exploration as adjunctive approaches to optimize treatment efficacy. Finally, we address current translational barriers and propose future directions, emphasizing multi-omics integration, spatial transcriptomics, and artificial intelligence (AI). This provides an objective, mechanistically grounded framework for advancing microbiota-guided personalized oncology in EC.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1955627","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:46:22Z","timestamp":1791189982000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota in esophageal cancer: mechanisms, clinical implications, and therapeutic potential"],"prefix":"10.3389","volume":"17","author":[{"given":"Yonghao","family":"Li","sequence":"first","affiliation":[{"name":"College of Integrated Chinese and Western Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Integrated Chinese and Western Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Integrated Chinese and Western Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Integrated Chinese and Western Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Gu'an County People's Hospital","place":["Langfang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Gu'an County People's Hospital","place":["Langfang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, The Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbing","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Integrated Chinese and Western Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"College of Integrated Chinese and Western Medicine, Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/SLA.0000000000005587","article-title":"A novel microbiome signature in gastric cancer: a two independent cohort retrospective analysis","volume":"276","author":"Abate","year":"2022","journal-title":"Ann. Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"556813","DOI":"10.3389\/fimmu.2020.556813","article-title":"Characterization of polysaccharide a response reveals interferon responsive gene signature and immunomodulatory marker expression","volume":"11","author":"Alvarez","year":"2020","journal-title":"Front. Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ags3.12014","article-title":"Review of the gut microbiome and esophageal cancer: pathogenesis and potential clinical implications","volume":"1","author":"Baba","year":"2017","journal-title":"Ann. Gastroenterol. Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2505118","DOI":"10.1080\/19490976.2025.2505118","article-title":"Intestinal and esophageal microbiota in esophageal cancer development and treatment","volume":"17","author":"Baba","year":"2025","journal-title":"Gut Microbes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1441290","DOI":"10.3389\/frmbi.2024.1441290","article-title":"Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing","volume":"3","author":"Barberio","year":"2024","journal-title":"Front. Microbiomes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"eady3571","DOI":"10.1126\/science.ady3571","article-title":"The specificity and structure of DNA cross-linking by the gut bacterial genotoxin colibactin","volume":"390","author":"Carlson","year":"2025","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41598-025-30385-8","article-title":"Butyrate prevents chemotherapy-induced gastrointestinal toxicity and microbial dysbiosis","volume":"16","author":"Cheatham","year":"2025","journal-title":"Sci. Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.08.028","article-title":"Metabolic diversity in human non-small cell lung cancer cells","author":"Chen","year":"2019","journal-title":"Mol. Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/ptr.7411","article-title":"Network pharmacology reveals potential functional components and underlying molecular mechanisms of Andrographis paniculata in esophageal cancer treatment","volume":"36","author":"Cheung","year":"","journal-title":"Phytother. Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/jgh.15941","article-title":"Alterations in gut microbiota of esophageal squamous cell carcinoma patients","volume":"37","author":"Cheung","year":"","journal-title":"J. Gastroenterol. Hepatol"},{"key":"B15","first-page":"2409","article-title":"Discovery of an interplay between the gut microbiota and esophageal squamous cell carcinoma in mice","volume":"10","author":"Cheung","year":"2020","journal-title":"Am. J. Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1002\/ptr.7815","article-title":"The effect of Andrographis paniculata water extract on palliative management of metastatic esophageal squamous cell carcinoma-A phase II clinical trial","volume":"37","author":"Chiu","year":"2023","journal-title":"Phytother. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1017\/S0007114513003681","article-title":"DHA suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages","volume":"111","author":"Choi","year":"2014","journal-title":"Br. J. Nutr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","article-title":"Mucosal microbiome dysbiosis in gastric carcinogenesis","volume":"67","author":"Coker","year":"2018","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40168-021-01208-5","article-title":"Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers","volume":"10","author":"Coker","year":"2022","journal-title":"Microbiome"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15330338251365700","DOI":"10.1177\/15330338251365700","article-title":"Harnessing the gut microbiome in cancer immunotherapy: mechanisms, challenges, and routes to personalized medicine-a systematic review","volume":"24","author":"Dayhimi","year":"2025","journal-title":"Technol. Cancer Res. Treat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1158\/1078-0432.CCR-20-4918","article-title":"Fecal microbiota transplantation from overweight or obese donors in cachectic patients with advanced gastroesophageal cancer: a randomized, double-blind, placebo-controlled, phase II study","volume":"27","author":"de Clercq","year":"2021","journal-title":"Clin. Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2320291","DOI":"10.1080\/19490976.2024.2320291","article-title":"The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance","volume":"16","author":"de Oliveira Alves","year":"2024","journal-title":"Gut Microbes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e074962","DOI":"10.1136\/bmj-2023-074962","article-title":"Advances in diagnosis and management of cancer of the esophagus","volume":"385","author":"Deboever","year":"2024","journal-title":"BMJ"},{"key":"B26","doi-asserted-by":"publisher","first-page":"106784","DOI":"10.1016\/j.micpath.2024.106784","article-title":"the gut microbiome of patients with esophageal cancer: a systematic review and meta-analysis based on 16S gene sequencing technology","volume":"193","author":"Deng","year":"2024","journal-title":"Microb. Pathog"},{"key":"B27","doi-asserted-by":"publisher","first-page":"104709","DOI":"10.1016\/j.micpath.2020.104709","article-title":"Dysbiosis of gut microbiota in patients with esophageal cancer","volume":"150","author":"Deng","year":"2021","journal-title":"Microb. Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e70093","DOI":"10.1002\/ctm2.70093","article-title":"Disentangling the molecular mystery of tumour-microbiota interactions: microbial metabolites","volume":"14","author":"Duan","year":"2024","journal-title":"Clin. Transl. Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41591-020-0908-2","article-title":"Colibactin DNA-damage signature indicates mutational impact in colorectal cancer","volume":"26","author":"Dziuba\u0144ska-Kusibab","year":"2020","journal-title":"Nat. Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41573-025-01211-7","article-title":"The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development","volume":"24","author":"Elkrief","year":"2025","journal-title":"Nat. Rev. Drug Discov"},{"key":"B31","doi-asserted-by":"publisher","first-page":"hoaf061","DOI":"10.1093\/hropen\/hoaf061","article-title":"Microbiome dysbiosis and endometriosis: a systematic scoping review of current literature and knowledge gaps","volume":"2025","author":"Facciotti","year":"2025","journal-title":"Hum. Reprod. Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s11684-024-1105-3","article-title":"Holistic integrative medicine declaration","volume":"18","author":"Fan","year":"2024","journal-title":"Front. Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.4251\/wjgo.v15.i8.1424","article-title":"Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer","volume":"15","author":"Fan","year":"2023","journal-title":"World J. Gastrointest. Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1080\/10408398.2022.2132464","article-title":"Postbiotics versus probiotics in early-onset colorectal cancer","volume":"64","author":"Feizi","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2174\/1389201023666221005103340","article-title":"Gut microbiota and colorectal cancer risk factors","volume":"24","author":"Feizi","year":"2023","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1087755","DOI":"10.3389\/fimmu.2023.1087755","article-title":"The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: a review","volume":"14","author":"Feng","year":"2023","journal-title":"Front. Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/gutjnl-2024-334338","article-title":"Faecalibacterium prausnitzii: one species with multiple potential implications in cancer research","volume":"74","author":"Formiga","year":"2025","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12866-016-0738-z","article-title":"16S rRNA gene sequencing of mock microbial populations-impact of DNA extraction method, primer choice and sequencing platform","volume":"16","author":"Fouhy","year":"2016","journal-title":"BMC Microbiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1016\/j.clnu.2021.10.004","article-title":"Impact of synbiotics treatment on bacteremia induced during neoadjuvant chemotherapy for esophageal cancer: a randomised controlled trial","volume":"40","author":"Fukaya","year":"2021","journal-title":"Clin. Nutr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0401223","DOI":"10.1128\/spectrum.04012-23","article-title":"Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma","volume":"12","author":"Gao","year":"2024","journal-title":"Microbiol. Spectr"},{"key":"B42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.biopha.2016.09.082","article-title":"Role of oral microbiome on oral cancers, a review","volume":"84","author":"Gholizadeh","year":"2016","journal-title":"Biomed. Pharmacother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1053\/j.gastro.2023.08.052","article-title":"Traditional medicine Pien Tze Huang suppresses colorectal tumorigenesis through restoring gut microbiota and metabolites","volume":"165","author":"Gou","year":"2023","journal-title":"Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"eabq4006","DOI":"10.1126\/scitranslmed.abq4006","article-title":"Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis","volume":"15","author":"Halsey","year":"2023","journal-title":"Sci. Transl. Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"189251","DOI":"10.1016\/j.bbcan.2024.189251","article-title":"Exploring the gut microbiome: a potential biomarker for cancer diagnosis, prognosis, and therapy","volume":"1880","author":"Han","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0123224","DOI":"10.1128\/mbio.01232-24","article-title":"Intestinal tissue response to Shiga toxin exposure","volume":"15","author":"Hanson","year":"2024","journal-title":"mBio"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/ijc.34191","article-title":"Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma","volume":"151","author":"Hao","year":"2022","journal-title":"Int. J. Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00595-022-02607-3","article-title":"Alterations in the gut microbiome in patients with esophageal carcinoma in response to esophagectomy and neoadjuvant treatment","volume":"53","author":"Hasuda","year":"2023","journal-title":"Surg. Today"},{"key":"B49","doi-asserted-by":"publisher","first-page":"eabc0217","DOI":"10.1126\/sciimmunol.abc0217","article-title":"Shiga toxin suppresses noncanonical inflammasome responses to cytosolic LPS","volume":"5","author":"Havira","year":"2020","journal-title":"Sci. Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","article-title":"Artificial intelligence-based multi-omics analysis fuels cancer precision medicine","volume":"88","author":"He","year":"2023","journal-title":"Semin. Cancer Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"953205","DOI":"10.3389\/fphar.2022.953205","article-title":"Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front. Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10096-019-03681-1","article-title":"The necessity to revise Koch's postulates and its application to infectious and non-infectious diseases: a mini-review","volume":"39","author":"Hosainzadegan","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12885-024-11982-8","article-title":"Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma\u2013based on microbiomics and metabolomics","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41467-021-21162-y","article-title":"Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells","volume":"12","author":"Iftekhar","year":"2021","journal-title":"Nat. Commun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.32725\/jab.2021.005","article-title":"Gut microbial dysbiosis and its association with esophageal cancer","volume":"19","author":"Ishaq","year":"2021","journal-title":"J. Appl. Biomed"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping of drug metabolism by the human gut microbiome","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"814","DOI":"10.14309\/ajg.0000000000002629","article-title":"Performance of prediction models for esophageal squamous cell carcinoma in general population: a systematic review and external validation study","volume":"119","author":"Jiang","year":"2024","journal-title":"Am. J. Gastroenterol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cac2.12645","article-title":"Current status and perspectives of esophageal cancer: a comprehensive review","volume":"45","author":"Jiang","year":"2025","journal-title":"Cancer Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2021790","DOI":"10.1080\/19490976.2021.2021790","article-title":"Hybrid, ultra-deep metagenomic sequencing enables genomic and functional characterization of low-abundance species in the human gut microbiome","volume":"14","author":"Jin","year":"2022","journal-title":"Gut Microbes"},{"key":"B60","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00335-018-9749-4","article-title":"Enterobacteria and host resistance to infection","volume":"29","author":"Kang","year":"2018","journal-title":"Mamm. Genome"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.chom.2024.06.010","article-title":"Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor","volume":"32","author":"Kim","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1025136","DOI":"10.3389\/fmicb.2022.1025136","article-title":"Virulence factors of Streptococcus anginosus - a molecular perspective","volume":"13","author":"Kury\u0142ek","year":"2022","journal-title":"Front. Microbiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/imm.12760","article-title":"The immune response to Prevotella bacteria in chronic inflammatory disease","volume":"151","author":"Larsen","year":"2017","journal-title":"Immunology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2078620","DOI":"10.1080\/19490976.2022.2078620","article-title":"Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer","volume":"14","author":"Lavelle","year":"2022","journal-title":"Gut Microbes"},{"key":"B66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","article-title":"Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment","volume":"24","author":"Le","year":"2025","journal-title":"Mol. Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"189476","DOI":"10.1016\/j.bbcan.2025.189476","article-title":"Research progress on gut microbiota in colorectal cancer immunotherapy","volume":"1880","author":"Li","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s12094-021-02754-y","article-title":"Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people","volume":"24","author":"Li","year":"2022","journal-title":"Clin. Transl. Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"781697","DOI":"10.3389\/fonc.2021.781697","article-title":"Gut microbiome features and chemotherapy response in gastrointestinal cancer","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e32770","DOI":"10.1016\/j.heliyon.2024.e32770","article-title":"Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"B71","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/wjtcm.wjtcm_11_21","article-title":"Network pharmacology evaluation method guidance-draft","volume":"7","author":"Li","year":"2021","journal-title":"World J. Tradit. Chin. Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.2147\/IJGM.S541736","article-title":"Alterations in the gut microbiota of patients with esophageal squamous cell carcinoma: a cross-sectional study conducted in a high-incidence region of China","volume":"18","author":"Li","year":"2025","journal-title":"Int. J. Gen. Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.20892\/j.issn.2095-3941.2023.0177","article-title":"Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis","volume":"21","author":"Li","year":"2023","journal-title":"Cancer Biol. Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1512683","DOI":"10.3389\/fimmu.2024.1512683","article-title":"Understanding the role of the gut microbiome in solid tumor responses to immune checkpoint inhibitors for personalized therapeutic strategies: a review","volume":"15","author":"Lim","year":"2024","journal-title":"Front. Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2452277","DOI":"10.1080\/19490976.2025.2452277","article-title":"From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy","volume":"17","author":"Lin","year":"2025","journal-title":"Gut Microbes"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2500933","DOI":"10.1183\/13993003.00933-2025","article-title":"Large-scale proteomic profiling identifies distinct inflammatory phenotypes in acute respiratory distress syndrome: a multicentre, prospective cohort study","volume":"67","author":"Lin","year":"2026","journal-title":"Eur. Respir. J"},{"key":"B77","doi-asserted-by":"publisher","first-page":"100530","DOI":"10.1016\/j.medj.2024.10.007","article-title":"Effects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic response","volume":"6","author":"Lin","year":"2025","journal-title":"Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"0529","DOI":"10.34133\/research.0529","article-title":"Unveiling the power of gut microbiome in predicting neoadjuvant immunochemotherapy responses in esophageal squamous cell carcinoma","volume":"7","author":"Liu","year":"2024","journal-title":"Research"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.7150\/ijbs.69331","article-title":"Gut microbiome in gastrointestinal cancer: a friend or foe?","volume":"18","author":"Liu","year":"2022","journal-title":"Int. J. Biol. Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"105242","DOI":"10.1016\/j.psj.2025.105242","article-title":"Do we need a standardized 16S rRNA gene amplicon sequencing analysis protocol for poultry microbiota research?","volume":"104","author":"Lyte","year":"2025","journal-title":"Poultry Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1676796","DOI":"10.3389\/fphys.2025.1676796","article-title":"The gut microbiome and gastrointestinal cancers: mechanisms, biomarkers and therapeutic opportunities","volume":"16","author":"Makkar","year":"2025","journal-title":"Front. Physiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"fuad039","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: a bacterial genus with promising human health applications","volume":"47","author":"Mart\u00edn","year":"2023","journal-title":"FEMS Microbiol. Rev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ijc.34033","article-title":"Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab","volume":"151","author":"Martini","year":"2022","journal-title":"Int. J. Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1245\/s10434-022-12166-z","article-title":"Fecal microbes associated with the outcomes after esophagectomy in patients with esophageal cancer","volume":"29","author":"Maruyama","year":"2022","journal-title":"Ann. Surg. Oncol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2174\/0115680096274860231111210214","article-title":"Investigating the influence of gut microbiota-related metabolites in gastrointestinal cancer","volume":"24","author":"Marzhoseyni","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"B86","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1007\/s00203-021-02422-3","article-title":"Production, structural and biochemical characterization relevant to antitumor property of acidic exopolysaccharide produced from Bacillus sp. NRC5","volume":"203","author":"Mohamed","year":"2021","journal-title":"Arch. Microbiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.clnu.2022.03.023","article-title":"Comparison of synbiotics combined with enteral nutrition and prophylactic antibiotics as supportive care in patients with esophageal cancer undergoing neoadjuvant chemotherapy: a multicenter randomized study","volume":"41","author":"Motoori","year":"2022","journal-title":"Clin. Nutr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clnu.2015.11.008","article-title":"Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients","volume":"36","author":"Motoori","year":"2017","journal-title":"Clin. Nutr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41564-026-02328-0","article-title":"Navigating multi-omic integration methods for human microbiome research","volume":"11","author":"Muller","year":"2026","journal-title":"Nat. Microbiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e13816","DOI":"10.1002\/jcsm.13816","article-title":"Stool microbiome features and weight change response to treatment for cancer cachexia","volume":"16","author":"Nasrah","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2497400","DOI":"10.1080\/19490976.2025.2497400","article-title":"Role of insulinemic and inflammatory dietary patterns on gut microbial composition and circulating biomarkers of metabolic health among older American men","volume":"17","author":"Nepal","year":"2025","journal-title":"Gut Microbes"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1016\/j.cell.2024.04.044","article-title":"Gut microbiome ecological topology as next-generation biomarkers for cancer immunotherapy","volume":"187","author":"Ning","year":"2024","journal-title":"Cell"},{"key":"B93","doi-asserted-by":"publisher","first-page":"0025","DOI":"10.34133\/csbj.0025","article-title":"Computational approach improves diagnostic performance based on tumor-associated autoantibodies in esophageal squamous cell carcinoma","volume":"35","author":"Nojima","year":"2026","journal-title":"Comput. Struct. Biotechnol. J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/s41591-021-01611-3","article-title":"FMT for patients with cancer","volume":"27","author":"O'Leary","year":"2021","journal-title":"Nat. Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00262-023-03608-y","article-title":"Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer","volume":"73","author":"Otsuka","year":"2024","journal-title":"Cancer Immunol. Immunother"},{"key":"B96","doi-asserted-by":"publisher","first-page":"9922","DOI":"10.3390\/ijms22189922","article-title":"Virulence factors of enteric pathogenic Escherichia coli: a review","volume":"22","author":"Pakbin","year":"2021","journal-title":"Int. Mol. Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"001156","DOI":"10.1099\/mic.0.001156","article-title":"A tale of two habitats: Bacteroides fragilis, a lethal pathogen and resident in the human gastrointestinal microbiome","volume":"168","author":"Patrick","year":"2022","journal-title":"Microbiology (Reading)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-018-0616-y","article-title":"Pathogen elimination by probiotic Bacillus via signalling interference","volume":"562","author":"Piewngam","year":"2018","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"100590","DOI":"10.1016\/j.prmcm.2025.100590","article-title":"The role of gut microbiota in traditional Chinese medicine processing: a general review","volume":"14","author":"Qiao","year":"2025","journal-title":"Pharmacol. Res. Mod. Chin. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e2205563","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10388-023-01004-0","article-title":"Gut microbiome can predict chemoradiotherapy efficacy in patients with esophageal squamous cell carcinoma","volume":"20","author":"Sasaki","year":"2023","journal-title":"Esophagus"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gutjnl-2019-318556","article-title":"International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis","volume":"68","author":"Scott","year":"2019","journal-title":"Gut"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.3390\/cancers16213644","article-title":"Fecal microbiome composition correlates with pathologic complete response in patients with operable esophageal cancer treated with combined chemoradiotherapy and immunotherapy","volume":"16","author":"Shaikh","year":"2024","journal-title":"Cancers"},{"key":"B105","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11274-021-03086-3","article-title":"Association of gut microbiomes with lung and esophageal cancer: a pilot study","volume":"37","author":"Shen","year":"2021","journal-title":"World J. Microbiol. Biotechnol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"812386","DOI":"10.3389\/fphar.2022.812386","article-title":"Chinese medicine formula Siwu-Yin inhibits esophageal precancerous lesions by improving intestinal flora and macrophage polarization","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Pharmacol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12916-025-04230-8","article-title":"Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer\/T-cell lymphoma by enhancing antitumor immunity","volume":"23","author":"Shi","year":"","journal-title":"BMC Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/gutjnl-2024-333530","article-title":"Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer\/T-cell lymphoma by dampening the JAK-STAT pathway","volume":"74","author":"Shi","year":"","journal-title":"Gut"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1038\/s41591-022-01965-2","article-title":"Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome","volume":"28","author":"Simpson","year":"2022","journal-title":"Nat. Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1103836","DOI":"10.3389\/fmicb.2022.1103836","article-title":"Butyrate producers, \u201cThe Sentinel of Gut\u201d: their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Microbiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1186\/s12967-024-05786-4","article-title":"Gut microbial and metabolomics profiles reveal the potential mechanism of fecal microbiota transplantation in modulating the progression of colitis-associated colorectal cancer in mice","volume":"22","author":"Song","year":"2024","journal-title":"J. Transl. Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1128\/CMR.00104-12","article-title":"Staphylococcal and streptococcal superantigen exotoxins","volume":"26","author":"Spaulding","year":"2013","journal-title":"Clin. Microbiol. Rev"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2515690X","DOI":"10.1177\/2515690X251324793","article-title":"The causal role of esophageal cancer and gut microbiota: a bidirectional mendelian randomization study","volume":"30","author":"Su","year":"2025","journal-title":"J. Evid. Based Integr. Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"001723","DOI":"10.1099\/jmm.0.001723","article-title":"Gut microbiota associated with the mitigation effect of synbiotics on adverse events of neoadjuvant chemotherapy in patients with esophageal cancer: a retrospective exploratory study","volume":"72","author":"Sugimoto","year":"2023","journal-title":"J. Med. Microbiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.surg.2012.02.021","article-title":"Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial","volume":"152","author":"Tanaka","year":"2012","journal-title":"Surgery"},{"key":"B116","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41579-021-00559-y","article-title":"Prevotella diversity, niches and interactions with the human host","volume":"19","author":"Tett","year":"2021","journal-title":"Nat. Rev. Microbiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00419-3","article-title":"Global burden and epidemiology of Barrett oesophagus and oesophageal cancer","volume":"18","author":"Thrift","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/jnci\/djae153","article-title":"Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort","volume":"116","author":"van den Ende","year":"2024","journal-title":"J. Natl. Cancer Inst"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1136\/gutjnl-2024-333378","article-title":"What defines a healthy gut microbiome?","volume":"73","author":"Van Hul","year":"2024","journal-title":"Gut"},{"key":"B120","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1186\/s12967-024-05762-y","article-title":"Blautia coccoides and its metabolic products enhance the efficacy of bladder cancer immunotherapy by promoting CD8 (+) T cell infiltration","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.18632\/aging.205547","article-title":"Causal relationship between gut microbiota and risk of esophageal cancer: evidence from Mendelian randomization study","volume":"16","author":"Wang","year":"2024","journal-title":"Aging"},{"key":"B122","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.7150\/jca.50318","article-title":"Characteristics and differences of gut microbiota in patients with different Traditional Chinese Medicine Syndromes of Colorectal Cancer and normal population","volume":"11","author":"Wang","year":"2020","journal-title":"J. Cancer"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e168112","DOI":"10.1172\/jci.insight.168112","article-title":"Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome","volume":"9","author":"Weh","year":"2024","journal-title":"JCI Insight"},{"key":"B125","doi-asserted-by":"publisher","first-page":"107148","DOI":"10.1016\/j.phrs.2024.107148","article-title":"The interactions between traditional Chinese medicine and gut microbiota in cancers: current status and future perspectives","volume":"203","author":"Wei","year":"2024","journal-title":"Pharmacol. Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","article-title":"Gut microbiota in colorectal cancer development and therapy","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.1038\/s41598-024-63774-6","article-title":"Bacteroidetes promotes esophageal squamous carcinoma invasion and metastasis through LPS-mediated TLR4\/Myd88\/NF-\u03baB pathway and inflammatory changes","volume":"14","author":"Wu","year":"2024","journal-title":"Sci. Rep"},{"key":"B128","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21037\/atm-22-1165","article-title":"Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy","volume":"10","author":"Xu","year":"2022","journal-title":"Ann. Transl. Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"107278","DOI":"10.1016\/j.phrs.2024.107278","article-title":"Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis","volume":"206","author":"Xu","year":"2024","journal-title":"Pharmacol. Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin. Microbiol. Rev"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","article-title":"Oesophageal cancer","volume":"404","author":"Yang","year":"2024","journal-title":"Lancet"},{"key":"B132","doi-asserted-by":"publisher","first-page":"146952","DOI":"10.1016\/j.ijbiomac.2025.146952","article-title":"Acylated Canna edulis starch improves type 2 diabetes in vitro and in vitro via gut microbiota-derived SCFA enrichment","volume":"322","author":"Yang","year":"2025","journal-title":"Int. J. Biol. Macromol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/bjs.9385","article-title":"Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy","volume":"101","author":"Yokoyama","year":"2014","journal-title":"Br. J. Surg"},{"key":"B134","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1080\/14796694.2025.2599371","article-title":"Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer","volume":"21","author":"Yoshinami","year":"2025","journal-title":"Fut. Oncol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"104453","DOI":"10.1016\/j.phrs.2019.104453","article-title":"Gut microbiota modulation with traditional Chinese medicine: a system biology-driven approach","volume":"148","author":"Yue","year":"2019","journal-title":"Pharmacol. Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1395267","DOI":"10.3389\/fcimb.2024.1395267","article-title":"Traditional Chinese herbal formulas modulate gut microbiome and improve insomnia in patients with distinct syndrome types: insights from an interventional clinical study","volume":"14","author":"Zeng","year":"2024","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1366975","DOI":"10.3389\/fonc.2024.1366975","article-title":"Changes in the gut microbiota of esophageal carcinoma patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"114981","DOI":"10.4251\/wjgo.v18.i2.114981","article-title":"Radiomics-based model for predicting neoadjuvant therapy response in esophageal cancer: limitations and suggestions","volume":"18","author":"Zhao","year":"2026","journal-title":"World J. Gastrointest. Oncol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"717242","DOI":"10.3389\/fonc.2021.717242","article-title":"Gut microbiota for esophageal cancer: role in carcinogenesis and clinical implications","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.chom.2026.02.019","article-title":"Gut microbiota-derived indole-3-lactic acid suppresses anti-PD-1 efficacy in esophageal squamous cell carcinoma","volume":"34","author":"Zhou","year":"2026","journal-title":"Cell Host Microbe"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1136\/gutjnl-2025-335946","article-title":"AI-empowered human microbiome research","volume":"75","author":"Zhou","year":"2026","journal-title":"Gut"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2501195","DOI":"10.1080\/19490976.2025.2501195","article-title":"Novel cross-feeding human gut microbes metabolizing tryptophan to indole-3-propionate","volume":"17","author":"Z\u00fcnd","year":"2025","journal-title":"Gut Microbes"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1955627\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:46:24Z","timestamp":1791189984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1955627\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":142,"alternative-id":["10.3389\/fmicb.2026.1955627"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1955627","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1955627"}}